Physician

Bassam N Estfan, MD

According to 2025 Medicare claims, Bassam Estfan, MD (NPI: 1821298035) practices medical oncology in the Cleveland, OH market, with the plurality of this provider's patient population coming from Cuyahoga, OH. This provider's primary affiliated billing organization is THE CLEVELAND CLINIC FOUNDATION (NPI: 1679525919; TIN: 340714585) and primary practice location at 44195-0001. Estfan is affiliated with the Cleveland Clinic Medicare ACO, LLC (ACO ID: A2729), participating under the MSSP model.

Estfan's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 166 traditional Medicare patients, billed 787 HCPCS/CPT codes, and received $42,052 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 267 prescription claims across 75 beneficiaries totaling $377,859 in drug costs, led by Eliquis (Apixaban). DME data shows 11 claims. Open Payments data shows 8 records totaling $77,541. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $34,611 and ending at $42,052. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $318,684 and ending at $377,859. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $11,744 to $0.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	158	445	$34,611
2016	179	530	$42,656
2017	189	538	$44,000
2018	208	637	$54,664
2019	241	634	$52,333
2020	183	470	$33,940
2021	184	470	$38,323
2022	152	344	$26,700
2023	158	412	$33,131
2024	166	787	$42,052

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	42	168	$318,684
2016	49	216	$330,810
2017	42	192	$582,585
2018	61	239	$216,553
2019	81	289	$663,271
2020	55	221	$417,116
2021	62	192	$57,674
2022	70	222	$407,575
2023	80	284	$511,918
2024	75	267	$377,859

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	118	$11,334
2016	N/R	79	$6,199
2017	N/R	93	$19,046
2018	22	60	$8,479
2019	N/R	76	$8,764
2020	N/R	36	$3,236
2021	N/R	20	$2,376
2022	N/R	42	$1,651
2023	N/R	62	$7,991
2024	N/R	11	$403

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	42	61	$109
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	24	61	$90
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	88	182	$72
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	75	109	$52
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	109	274	$12

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	11	390	$7,610
Olanzapine	Olanzapine	21	870	$356
Ondansetron Hcl	Ondansetron Hcl	31	361	$226
Prochlorperazine Maleate	Prochlorperazine Maleate	18	174	$160
Pantoprazole Sodium	Pantoprazole Sodium	12	720	$124

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J8521	Capecitabine, oral, 500 mg	N	N/R	11	$403

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	6	$3,066	Sirtex Medical Inc
Research Payments	Reported research-related payment or transfer-of-value amount.	2	$74,475	Amgen Inc.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Bassam N. Estfan, MD?

Tedicare shows public-source Medicare data for Bassam N. Estfan, MD (NPI 1821298035), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Bassam N. Estfan, MD have ACO affiliation data?

Bassam N. Estfan, MD is shown with ACO affiliation data for Cleveland Clinic Medicare ACO, LLC (MSSP, ACO ID A2729).

What billing organization is linked to Bassam N. Estfan, MD?

Bassam N. Estfan, MD is linked to THE CLEVELAND CLINIC FOUNDATION (billing NPI 1679525919) in the available physician profile data.

Does Bassam N. Estfan, MD have Open Payments data?

Bassam N. Estfan, MD has 8 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.